Arch Therapeutics Inc (ARTH)

[jsmith123343]

The event that will really pop this (if no partnership till then) is the internal bleeding trials. Really hope they start that very soon like January. They have already done tons of preclinical comparison with many of the leading competitors, and the results are amazing. Its all posted on this site here.
A year from now (mid 2017, assuming CE application done, CE approved, internal bleeding trial complete at Ireland, we will be seeing $5 (even without partnership, and minimal dilution of $4-5 million).

With partnership before that, we see $2.5 right away.